Beverly Hills Private Wealth’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.67M Buy
13,899
+8,347
+150% +$964K 0.28% 101
2025
Q4
$584K Sell
5,552
-170
-3% -$16K 0.1% 159
2025
Q3
$480K Sell
5,722
-170
-3% -$14K 0.08% 190
2025
Q2
$466K Sell
5,892
-365
-6% -$29K 0.09% 184
2025
Q1
$562K Sell
6,257
-19,524
-76% -$1.82M 0.11% 159
2024
Q4
$2.56M Sell
25,781
-4,171
-14% -$430K 0.52% 51
2024
Q3
$3.4M Sell
29,952
-7,001
-19% -$832K 0.69% 32
2024
Q2
$4.57M Sell
36,953
-2,553
-6% -$329K 0.99% 18
2024
Q1
$5.21M Buy
39,506
+228
+0.6% +$28.1K 1.2% 11
2023
Q4
$4.28M Buy
39,278
+66
+0.2% +$6.85K 1.12% 19
2023
Q3
$4.04M Sell
39,212
-32,938
-46% -$3.55M 1.2% 17
2023
Q2
$7.58M Buy
72,150
+31,792
+79% +$3.61M 1.25% 14
2023
Q1
$4.29M Buy
40,358
+11,519
+40% +$1.24M 1.33% 12
2022
Q4
$3.2M Buy
+28,839
New +$2.95M 1.4% 12

Other funds holding MRK

Beverly Hills Private Wealth's MRK Position: Q1 2026 in Review

Beverly Hills Private Wealth increased its Merck (MRK) stake by 150% in Q1 2026, buying an estimated $964K and bringing the position to 13,899 shares worth $1.67M. The position accounts for 0.28% of the portfolio, ranked #101.

Beverly Hills Private Wealth first reported a position in MRK in Q4 2022 and has held it in 14 quarters since. The position peaked at $7.58M in Q2 2023. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Beverly Hills Private Wealth held 13,899 shares of Merck worth $1.67M as of Q1 2026.
  • Beverly Hills Private Wealth bought 8,347 Merck shares in Q1 2026, an estimated $964K.
  • Merck made up 0.28% of Beverly Hills Private Wealth's portfolio in Q1 2026, its #101 holding.
  • Beverly Hills Private Wealth first reported a position in Merck in Q4 2022 and has held it in 14 quarters since.
  • Beverly Hills Private Wealth's Merck position peaked at $7.58M in Q2 2023.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Beverly Hills Private Wealth's 13F filing for Q1 2026, filed 4 May 2026.